Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Schliemann, W.; Schliemann, B.
    beta-D-Glucosidasen (EC 3.2.1.21) und glucosylceramidasen (EC 3.2.1.45) des Menschen (1982), Pharmazie, 4, 243-250.
    View publication on PubMed

Application

EC Number Application Comment Organism
3.2.1.45 medicine Gaucher disease, sphingolipoidose Homo sapiens

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.2.1.45 (1R,2R,3S,4S,5R,6S)-7-oxabicyclo[4.1.0]heptane-2,3,4,5-tetrol
-
 Bos taurus
3.2.1.45 (1R,2R,3S,4S,5R,6S)-7-oxabicyclo[4.1.0]heptane-2,3,4,5-tetrol
-
 Homo sapiens
3.2.1.45 (1R,2R,3S,4S,5R,6S)-7-oxabicyclo[4.1.0]heptane-2,3,4,5-tetrol
-
 Rattus norvegicus

Organism

EC Number Organism UniProt Comment Textmining
3.2.1.45 Bos taurus
-
-
-
3.2.1.45 Homo sapiens
-
-
-
3.2.1.45 Mus musculus
-
-
-
3.2.1.45 Rattus norvegicus
-
-
-
3.2.1.45 Sus scrofa
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
3.2.1.45 brain
-
 Mus musculus
-
3.2.1.45 brain
-
 Homo sapiens
-
3.2.1.45 brain
-
 Rattus norvegicus
-
3.2.1.45 brain
-
 Bos taurus
-
3.2.1.45 intestine
-
 Homo sapiens
-
3.2.1.45 intestine
-
 Bos taurus
-
3.2.1.45 liver
-
 Mus musculus
-
3.2.1.45 liver
-
 Homo sapiens
-
3.2.1.45 liver
-
 Rattus norvegicus
-
3.2.1.45 monocyte
-
 Homo sapiens
-
3.2.1.45 placenta
-
 Homo sapiens
-
3.2.1.45 spleen
-
 Mus musculus
-
3.2.1.45 spleen
-
 Homo sapiens
-
3.2.1.45 spleen
-
 Rattus norvegicus
-
3.2.1.45 spleen
-
 Bos taurus
-
3.2.1.45 stomach
-
 Homo sapiens
-